Accessibility Menu
Mushrooms logo

Mushrooms(OTC) MSRM

Market Cap$567.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-88%
1 Year-22%
1 Month-33%
$0.01
-17.61%
-0.00Today
Mushrooms last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-31
Mushrooms stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.69%USD 0.012026-07-23
1 month-33.14%USD 0.022026-07-01
3 month-22%USD 0.022026-05-01
Year to date-52.05%USD 0.022025-12-31
1 year-22%USD 0.022025-07-31
3 year-67.09%USD 0.042023-08-01
5 year-88.3%USD 0.102021-07-30
Since inception-99.99%USD 250.002006-11-20

Mushrooms Financials at a Glance

Market Cap

$567.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.35K

Net Income (TTM)

-$157.65K

EPS (TTM)

-$0.00

P/E Ratio

-3.84

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$0.01

Volume

40,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

N/A

MSRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mushrooms

Mushrooms Inc. is focused on acquiring and merging with small to mid-size companies in the mushroom industry. Founded in 2002 and based in Estero, Florida, the company aims to capitalize on the growing demand for mushroom-based products.

Products and Services
  • Acquisition and merger services for mushroom-focused companies
  • Development of innovative mushroom-based products
  • Consulting services for industry stakeholders
Growth Outlook
  • Increasing consumer interest in health benefits of mushrooms
  • Expansion opportunities in the organic and functional food markets
  • Strategic partnerships to enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of $0, indicating a focus on restructuring
  • Trailing twelve months (TTM) net income of -$1.33 million, reflecting ongoing investment
  • Cash and cash equivalents of $40.06, providing liquidity for operations
Mushrooms Inc. has undergone significant changes since its rebranding from Marijuana Strategic Ventures Inc. in October 2022. The company is strategically positioned to leverage the growing interest in mushrooms, particularly in health and wellness sectors. Despite recent financial challenges, including a TTM net income of -$1.33 million, the company maintains a focus on restructuring and potential growth through acquisitions. The current cash position of $40.06 allows for operational flexibility as the company navigates its strategic objectives. Investors may find the evolving landscape of the mushroom industry and the company's commitment to innovation and growth appealing.
AI Generated • Jul 14, 2026

Industry

Pharmaceuticals

CEO

Kimberly Carlson

Headquarters

Estero, FL 33928, US

MSRM Financials

Key Financial Metrics (TTM)

Gross Margin

-46.11%

Operating Margin

-6881.28%

Net Income Margin

-6713.12%

Return on Equity

279.94%

Return on Capital

N/A

Return on Assets

-1275.49%

Earnings Yield

-26.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$567.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

39.94M

Volume

40.00K

Avg. Volume

11.33K

Financials (TTM)

Gross Profit

-$1.08K

Operating Income

-$161.60K

EBITDA

-$159.40K

Operating Cash Flow

$4.64K

Capital Expenditure

$4.06

Free Cash Flow

$4.64K

Cash & ST Invst.

$40.06

Total Debt

$25.00K

Mushrooms Performance Analysis

Mushrooms annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 1,097N/A
20252025-12-31USD 2,384117.3%
Mushrooms sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30208.1%
Q32025-09-301885.9%
Q42025-12-31-95.5%
Q12026-03-31-100.0%
Mushrooms annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-41.3%
20232023-12-31USD -0.00-95.9%
20242024-12-31USD -0.0040.0%
20252025-12-31USD -0.00-57.1%
Mushrooms sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31600.0%
Q12026-03-31-720.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$546.00

-7.5%

Gross Margin

0.00%

N/A

Market Cap

$567.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$94.53K

N/A

Employees

6

N/A

Net Income

-$133.14K

-18865.4%

EBITDA

-$137.00K

-81692.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$40.06

-69.9%

Total Debt

$25.00K

-11.4%

Accounts Receivable

$0.00

N/A

Inventory

$8.16K

N/A

Long Term Debt

$25.00K

+0.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-12.75%

N/A

Return on Invested Capital

4.35%

N/A

Free Cash Flow

-$470.00

+97.4%

Operating Cash Flow

-$465.00

+97.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLMNMillennium Prime, Inc.
$0.00+0.00%
AAGRAfrican Agriculture Holdings Inc.
$0.01+0.00%
ASIIAccredited Solutions Inc
$0.00+0.00%
SHMPNaturalShrimp Incorporated
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About MSRM

What is the current price of Mushrooms?

Mushrooms is trading at $0.01 per share.

What is the 52-week range for Mushrooms?

Over the past 52 weeks, Mushrooms has traded between $0.01 and $0.04.

How much debt does Mushrooms have?

As of the most recent reporting period, Mushrooms reported total debt of $25.00K.

How much cash does Mushrooms have on hand?

Mushrooms reported $40.06 in cash and cash equivalents in its most recent financial results.

What is Mushrooms’s dividend yield?

Mushrooms does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.